Time to end secret data laboratories—starting with the CDC
The American people are waking up to the fact that too many public health leaders have not always been straight with them. Despite housing treasure…
Thought Leader: Marty Makary
Scott Gottlieb on CDC Vaccine Review & Healthcare Trends
Scott Gottlieb, former FDA commissioner and current board member of Pfizer and Illumina, joins CNBC’s ‘Squawk on the Street’ to discuss expectations for a CDC panel’s review of vaccines this week, what’s most at stake, and much more.
Dr. Scott Gottlieb, former Commissioner of the U.S. Food and Drug Administration, is one of today’s most trusted voices in healthcare policy and pharmaceutical innovation. With deep experience at the highest levels of public health leadership, Dr. Gottlieb offers expert analysis on the evolving landscape of healthcare regulation, drug development, biopharma trends, and global market forces such as tariffs and supply chain disruption. A physician, policymaker, and thought leader, he regularly advises organizations navigating complex health and economic challenges. His insights are essential for anyone seeking clarity at the intersection of science, policy, and innovation. For speaking inquiries, contact WWSG.
Relevant posts
David Frum: How Harris Roped a Dope
This piece is by WWSG exclusive thought leader, David Frum. Vice President Kamala Harris walked onto the ABC News debate stage with a mission: trigger…
Thought Leader: David Frum
Michael Baker: Ukraine’s Faltering Front, Polish Sabotage Foiled, & Trump vs. Kamala
In this episode of The President’s Daily Brief with Mike Baker: We examine Russia’s ongoing push in eastern Ukraine. While Ukrainian forces continue their offensive…
Thought Leader: Mike Baker
More with this speaker
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb
Scott Gottlieb: China’s edge over U.S. biotech
Thought Leader: Scott Gottlieb